CANNAPHARMARX, INC. Finance Lease, Right-of-Use Asset, Amortization
CANNAPHARMARX, INC. (CPMD) reported Finance Lease, Right-of-Use Asset, Amortization of $41.87 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-03-31
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $10.86K, a 12.09% increase year-over-year.
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $10.26K, a 87.02% decline year-over-year.
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was $9.50K, a 87.95% decline year-over-year.
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $11.21K, a 85.98% decline year-over-year.
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $41.87K, a 83.08% decline from fiscal 2024.
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $247.48K, a 150.06% increase from fiscal 2023.
- CANNAPHARMARX, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $98.97K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $21.12K derived: sum of 2 quarters · filed 2026-03-31 | $30.62K derived: sum of 3 quarters · filed 2026-03-31 | $41.87K 10-K · filed 2026-03-31 |
| 2025-09-30 | $10.26K 10-Q · filed 2025-11-14 | $19.76K derived: sum of 2 quarters · filed 2025-11-14 | $31.00K 10-Q · filed 2025-11-14 | $40.66K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | $9.50K 10-Q · filed 2025-08-14 | $20.75K 10-Q · filed 2025-08-14 | $30.40K derived: sum of 3 quarters · filed 2026-03-31 | $109.45K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $11.21K 10-Q · filed 2025-05-16 | $20.90K derived: sum of 2 quarters · filed 2026-03-31 | $99.95K derived: sum of 3 quarters · filed 2026-03-31 | $178.76K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | $9.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $88.74K derived: sum of 2 quarters · filed 2026-03-31 | $167.55K derived: sum of 3 quarters · filed 2026-03-31 | $247.48K 10-K · filed 2026-03-31 |
| 2024-09-30 | $79.05K 10-Q · filed 2025-11-14 | $157.86K derived: sum of 2 quarters · filed 2025-11-14 | $237.79K 10-Q · filed 2025-11-14 | $96.38K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $78.81K 10-Q · filed 2025-08-14 | $158.74K 10-Q · filed 2025-08-14 | $17.33K derived: sum of 3 quarters · filed 2025-08-14 | $97.71K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $79.96K 10-Q · filed 2025-05-16 | -$61.48K derived: sum of 2 quarters · filed 2025-05-16 | $18.91K derived: sum of 3 quarters · filed 2025-05-16 | |
| 2023-12-31 | -$141.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | -$61.05K derived: sum of 2 quarters · filed 2025-04-10 | $98.97K 10-K · filed 2025-04-10 | |
| 2023-09-30 | $80.39K 10-Q · filed 2024-11-14 | $240.41K 10-Q · filed 2024-11-14 | ||
| 2023-03-31 | $79.72K 10-Q · filed 2024-06-25 |